Skip to content

{ Category Archives } Musculoskeletal disorders

Open Patient Enrollment for MossRehab Trials

ZolpidemPrincipal Investigator: John Whyte, MD, PhD Trial location: MossRehab   This trial seeks to define more precisely the proportion of patients in the vegetative and minimally conscious states (VS/MCS) who have a clinically meaningful response to zolpidem with improvement in their level of consciousness. It will use cutting-edge research methods (functional neuroimaging, event related potentials, [...]

Answering the Call: MossRehab Helps Outpatients Stay Connected with Lifelong Living Programs

When persons are discharged back to their homes following an acute inpatient rehab stay, celebration can quickly give way to bewilderment. Even after months or years of functional improvement, they may be stunned by the difficulty of common household tasks. Worse still, some may experience a profound sense of isolation, as they discover that participating [...]

MossRehab to Perform Exclusive U.S.Trial of ReWalk(TM)

MossRehab will soon begin the exclusive U.S. clinical trial for a new assistive technology called the ReWalk. The ReWalk is a motorized exoskeleton suit that enables patients with lower limb disabilities, including complete paralysis, to independently engage in ambulatory activities, such as standing, walking and in some cases climbing stairs.The ReWalk consists of a lightweight [...]

MossRehab’s Patient Outcomes in 2007 Exceed National and Regional Averages

MossRehab is committed to optimizing our patients’ function and quality of life. As part of this commitment to quality, we grade ourselves each year by quantifying the functional gains our patients make. Using the Functional Independence Measure™ (FIM™), an instrument widely employed in the rehabilitation industry, we track our patient’s admission and discharge status in [...]